| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/12/2006 | EP1679308A1 Novel indazole derivative |
| 07/12/2006 | EP1679073A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(imino-heterocyclyl)-phenyl-amide derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 07/12/2006 | EP1678258A1 Cyanine dye labelling reagents |
| 07/12/2006 | EP1678170A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas |
| 07/12/2006 | EP1678167A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 07/12/2006 | EP1678163A1 Novel imidazole derivatives and their use as pharmaceutical agents |
| 07/12/2006 | EP1678147A1 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases |
| 07/12/2006 | EP1678145A2 Benzimidazoles useful as modulators of ion channels |
| 07/12/2006 | EP1678144A1 1,5,7-TRISUBSTITUTED BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABA-a RECEPTOR COMPLEX |
| 07/12/2006 | EP1678133A1 Sequence selective pyrrole and imidazole polyamide metallocomplexes |
| 07/12/2006 | EP1677786A1 5-substituted 2-(phenylmethyl)thio-4-phenyl-4h-1,2,4-triazole derivatives and related compounds as gaba-agonists for the treatment of urinary incontinence and related diseases |
| 07/12/2006 | CN1802368A Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
| 07/12/2006 | CN1802357A Aminopyrimidine derivatives and their medical use |
| 07/12/2006 | CN1802351A Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 07/12/2006 | CN1802159A 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
| 07/12/2006 | CN1800179A Method for preparing candestartan |
| 07/12/2006 | CN1800165A Cationic symmetric 2-imidazolium diazo compounds with a cationic linking group, compositions comprising them, a dying process and kit thereof |
| 07/12/2006 | CN1263746C Pyridazinone derivatives |
| 07/11/2006 | US7074921 Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds |
| 07/11/2006 | US7074814 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antiarthritic agents ; psoriasis |
| 07/11/2006 | US7074810 Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme |
| 07/11/2006 | US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 07/11/2006 | US7074800 Quinazoline derivatives as angiogenesis inhibitors |
| 07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 07/11/2006 | US7074796 High affinity for D4 receptors; treatment of psychological disorders such as schizophrenia, generalised anxiety disorder, panic disorder, and obsessive compulsive disorder. |
| 07/11/2006 | US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074789 Kinase inhibitors |
| 07/11/2006 | US7074786 Histogranin-like peptides, processes for their preparation and uses thereof |
| 07/11/2006 | US7074784 Medicaments against viral diseases |
| 07/11/2006 | US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 07/11/2006 | US7074781 E.g., 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide; control of urinary incontinence and bleeding disorders. |
| 07/11/2006 | US7074534 Polymeric charge transport compositions and electronic devices made with such compositions |
| 07/11/2006 | CA2269810C N-substituted 2-cyanopyrrolidines |
| 07/11/2006 | CA2260999C Heterocyclic compounds, their production and use in tyrosine kinase inhibition |
| 07/11/2006 | CA2246783C Mcbi analogs of cc-1065 and the duocarmycins |
| 07/11/2006 | CA2208630C 4-amino-2-ureidopyrimidine-5-carboxamides, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 07/11/2006 | CA2206532C Novel amidinonaphthyl derivative or salt thereof |
| 07/06/2006 | WO2006071958A1 Compounds useful as chemokine receptor antagonists |
| 07/06/2006 | WO2006071644A1 Selective inhibitors of erk protein kinases and uses therof |
| 07/06/2006 | WO2006070284A1 Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors |
| 07/06/2006 | WO2006070202A1 Pyrazole derivatives having kinase modulating activity |
| 07/06/2006 | WO2006070198A1 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
| 07/06/2006 | WO2006070195A1 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases |
| 07/06/2006 | WO2006069740A1 2, 5 and 2, 6-disubstituted benzazole analogues useful as protein kinase inhibitors |
| 07/06/2006 | WO2006069525A1 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof |
| 07/06/2006 | WO2006053274A3 2-amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 07/06/2006 | WO2006050389A3 Pyridazine compounds, compositions and methods |
| 07/06/2006 | WO2006047415A3 FACTOR Xa COMPOUNDS |
| 07/06/2006 | WO2006011859A3 Preparation of hydrochloride salts of tetrazole derivative |
| 07/06/2006 | WO2005041867A8 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3’(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline |
| 07/06/2006 | US20060149080 Process for preparing optically active cyclic amines |
| 07/06/2006 | US20060149078 Olmesartan medoxomil with reduced levels of impurities |
| 07/06/2006 | US20060149072 Selective to alpha2B or alpha2C adrenergic receptors, minimal cardivascular or sedatory activity; treating visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
| 07/06/2006 | US20060149066 Imidazole derivatives |
| 07/06/2006 | US20060149063 N-(4-Heptadecyl-6-oxo-1,6-dihydropyrimidin-2-yl)-N'-phenylguanidine; low viscosity values at the jetting temperature of a hot melt ink jet printer |
| 07/06/2006 | US20060149062 Sulfanyl substituted phenyl methanones |
| 07/06/2006 | US20060149061 2-chloro-4-(3-pyridyl)-pyrimidine is reacted with 2-amino-4-nitrotoluene to obtain N-(2-methyl-5-nitrophenyl)-4-(3-pyridyl)-2-pyrimidine-amine, hydrogenated to N-(5-amino-2-methyl)-4-(3-pyridyl)-pyrimidine-amine, reacted with 4-(4-methyl-piperazine-1-ylmethyl)-benzoyl chloride; avoids use of cyanamide |
| 07/06/2006 | US20060149059 Phthalazinone derivatives |
| 07/06/2006 | US20060148880 3-(Guanidinylcarbonylmethyl)-substituted; inhibit the cellular sodium-proton antiporter, in particular NHE1; antiarrhythmic agents;cardioprotective for infarction prophylaxis and treatment; preventing ischemia-induced damage |
| 07/06/2006 | US20060148859 Substituted pyridyloxyalkylamides and their use as fungicides |
| 07/06/2006 | US20060148858 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity |
| 07/06/2006 | US20060148857 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 07/06/2006 | US20060148856 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 07/06/2006 | US20060148854 Chemical compounds |
| 07/06/2006 | US20060148849 Quinoline derivatives, process of synthesis and medicaments containing these derivatives |
| 07/06/2006 | US20060148845 In which a pyrrole ring is directly bonded to a 6,5-condensed ring system, such as a benzimidazole, imidazopyridine or imidazopyrimidine system; especially effective against drug resistant bacteria such as MRSA, PRSP, or VRE |
| 07/06/2006 | US20060148830 Lpa receptor antagonist |
| 07/06/2006 | US20060148824 Administering compounds such as 6-Chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine for inhibiting a protein kinase |
| 07/06/2006 | US20060148823 Tricyclic delta -opioid modulators; 10-(1-Benzyl-piperidin-4-yl)-6-hydroxy-10H-phenoxazine-3-carboxylic acid diethylamide; immunosuppressants, antiinflammatory agents, depression, Parkinson's disease; reduced side effects; veterinary composition to treat mild to severe pain in warm-blooded animals |
| 07/06/2006 | US20060148819 Chemical compounds |
| 07/06/2006 | US20060148818 Novel tetraydrospiro(piperdine-2,7'- pyrrolo{3,2-b}pyridine derivatives and novel in-dole derivatives useful in the treatment of 5-ht6 receptor-related disorders |
| 07/06/2006 | US20060148817 Pyrazole compounds |
| 07/06/2006 | US20060148816 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/06/2006 | US20060148815 4-Phenyl-1-piperazinyl, -piperidinyl and-tetrahydropyridyl derivatives |
| 07/06/2006 | US20060148814 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are antagonists of the mGluR5 receptor |
| 07/06/2006 | US20060148811 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent |
| 07/06/2006 | US20060148809 For the therapy of deleterious neurological complaints; anxiolytic agents;cognitive disorders; good affinity as ligands for the alpha 2 and or alpha 3 and or alpha 5 subunit of the human GABAA receptor; 3-(6-Phenylpyridazin-4-yl)thiophene-2-carboxylic Acid Methyl Ester |
| 07/06/2006 | US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents |
| 07/06/2006 | US20060148794 Neuropeptide Y antagonist; antiarthritic agents; cardiovascular disorders; antidiabetic agents; kidney disorders; eating disorders; obesity |
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148791 Glutamate receptor antagonists |
| 07/06/2006 | US20060148790 Benzodiazepine cgrp receptor antagonists |
| 07/06/2006 | US20060148779 Calcitonin Gene-Related Peptide (CGRP) antagonists for migraine and cluster headaches; 5'-acylamino-spiro[imidazolidine-4,2'-indane]-2,5-dione derivatives |
| 07/06/2006 | US20060148764 5-phenypyrimidines their preparation compositions comprising them and their use |
| 07/06/2006 | US20060148649 Substituted n-aryl nitrogen heterocycles |
| 07/06/2006 | US20060147948 bioassay with compounds having dimaleimide groups attached directly to fluorescent cores, whose latent fluorescence is quenched until maleimide groups undergo thiol addition reaction, for detecting target proteins having sterically unhindered sulfhydryl groups; fluorescence resonance energy transfer |
| 07/06/2006 | US20060145145 Tertiary amine compounds, organic semiconductor devices using the same and organic electroluminescence devices using the same |
| 07/06/2006 | DE112004001603T5 TGF-β-Genexpressionsinhibitor TGF-β gene expression inhibitor |
| 07/06/2006 | DE102004061751A1 Cyanoguanidin-substituierte Pyrazoline Cyanoguanidino substituted pyrazolines |
| 07/06/2006 | DE102004061748A1 Azetidin-substituierte Pyrazoline Azetidine-substituted pyrazolines |
| 07/06/2006 | CA2594345A1 Compositions and methods of treating cell proliferation disorders |
| 07/06/2006 | CA2594251A1 Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors |
| 07/06/2006 | CA2593993A1 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases |
| 07/06/2006 | CA2592514A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 07/06/2006 | CA2592509A1 Benzazole analogues and uses thereof |
| 07/06/2006 | CA2590586A1 Substituted biaryl analogues |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676837A1 Process for producing aminopyrrolidine derivative and intermediate compound |